FDA Drug recall D-0769-2021
Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc
- FDA Drug
- Class II
- ongoing
- Published 2021-09-01
On 2021-09-01 the FDA classified a Class II recall of Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc by Teligent Pharma, citing defective container: possibility for lack of seal integrity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0769-2021 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2021-07-29 |
| Published | 2021-09-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teligent Pharma |
| Distribution | US |
Product
Erythromycin Topical Solution USP, 2%, 60mL bottle, Rx only, Teligent Pharma, Inc. Buena, NJ 08310, NDC 52565-027-59
Reason
Defective container: possibility for lack of seal integrity.
Identifiers
| code_info | Lot #: 14892, Exp 1/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0769-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.